SVAX STUDY: STUDY OF THE LEVELS OF ANTIBODIES AND STUDY OF THE ACTIVATION OF COAGULATION IN SUBJECTS THAT HAVE RECEIVED ANTI-COVID-19 VACCINATION.

Categories

This project aims to evaluate the growth of anti-SARS-CoV2 antibodies in subjects who are vaccinated with various types of vaccines and how long these antibodies last over time. Both subjects who have had the infection and subjects who have never contracted Covid-19 are enrolled in the study, and various types of antibodies are evaluated. In addition, given the rare reports of thrombosis or decreased platelets in vaccinated subjects, a study of the markers of thrombosis and procoagulant proteins will also be performed.